Now showing items 1-4 of 4

    • Association of baseline CD4+ cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients 

      Aldámiz-Echevarría, Teresa; González-García, Juan; Von Wichmann, Miguel A.; Crespo, Manel; López-Aldeguer, José; Quereda, Carmen; Téllez, María J.; Galindo, María J.; Sanz, José; Santos, Ignacio; Guardiola Tey, Josep Maria; Bellón, José M.; Montes, Marisa; Berenguer, Juan; GESIDA HIV-HCV Cohort Study Group (Annals of Hepatology, 2015)
      Background and rationale for the study. We assessed the association of CD4+ T-cell counts and HIV-RNA onsustained viral response (SVR) after therapy with pegylated interferon and ribavirin (PR) in HIV/HCV ...
    • Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV–HCV co-infected patients: final results of the Spanish BOC HIV–HCV Study 

      Laguno, M.; Von Wichmann, M. A.; Van den Eynde, E.; Navarro, J.; Cifuentes, Carmen; Murillas, J.; Veloso, S.; Martínez-Rebollar, M.; Guardiola, J.M.; Jou, A.; Gómez-Sirvent, J.L.; Cervantes, M.; Pineda, J.A.; López-Calvo, S.; Carrero, Ana; Montes, M.L.; Deig, E.; Tapiz, A.; Ruiz-Mesa, J.D.; Cruceta, A.; de Lazzari, E.; Mallolas, Josep (International Journal of Infectious Diseases, 2016-12)
      Introduction: Boceprevir (BOC) was one of the first oral inhibitors of hepatitis C virus (HCV) NS3 protease to be developed. This study assessed the safety and efficacy of BOC + pegylated interferon-α ...
    • Eradication of hepatitis C virus and non-liver-related non–acquired immune deficiency syndrome–related events in human immunodeficiency virus/hepatitis C virus coinfection 

      Berenguer, Juan; Rodríguez-Castellano, Elena; Carrero, Ana; Von Wichmann, Miguel A.; Montero, Marta; Galindo, María J.; Mallolas, Josep; Crespo, Manuel; Téllez, María J.; Quereda, Carmen; Sanz, José; Barros, Carlos; Tural, Cristina; Santos, Ignacio; Pulido, Federico; Guardiola Tey, Josep Maria; Rubio, Rafael; Ortega, Enrique; Montes, María L.; Jusdado, Juan J.; Gaspar, Gabriel; Esteban, Herminia; Bellón, José M.; González-García, Juan; GESIDA HIV-HCV Cohort Study Group (Hepatology, 2017)
      We assessed non-liver-related non–acquired immunodeficiency syndrome (AIDS)-related (NLR-NAR) events and mortalityin a cohort of human immunodeficiency virus (HIV)/hepatitis C virus (HCV)–coinfected ...
    • Human immunodeficiency virus/hepatits C virus coinfection in Spain: elimination Is feasible, but the burden of residual cirrhosis will be significant 

      Berenguer, Juan; Jarrín, Inmaculada; Pérez-Latorre, Leire; Hontañón, Víctor; Vivancos, María J.; Navarro, Jordi; Téllez, María J.; Guardiola Tey, Josep Maria; Iribarren, José A.; Rivero-Juárez, Antonio; Márquez, Manuel; Artero, Arturo; Morano, Luis; Santos, Ignacio; Moreno, Javier; Fariñas, María C.; Galindo, María J.; Hernando, María A.; Montero, Marta; Cifuentes, Carmen; Domingo, Pere; Sanz, José; Domíngez, Lourdes; Ferrero, Oscar L.; De la Fuente, Belén; Rodríguez, Carmen; Reus, Sergio; Hernández-Quero, José; Gaspar, Gabriel; Pérez-Martínez, Laura; García, Coral; Force, Lluis; Veloso, Sergio; Losa, Juan E.; Vilaró, Josep; Bernal, Enrique; Arponen, Sari; Ortí, Amat J.; Chocarro, Ángel; Teira, Ramón; Alonso, Gerardo; Silvariño, Rafael; Vegas, Ana; Geijo, Paloma; Bisbe, Josep; Esteban, Herminia; González-García, Juan; GeSIDA 8514 Study Group (Open Forum Infectious Diseases, 2018-01)
      Background: We assessed the prevalence of antibodies against hepatitis C virus (HCV-Abs) and active HCV infection in patients infected with human immunodeficiency virus (HIV) in Spain in 2016 and compared ...